Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

The peach gene CTG134 helps control the interaction between auxin and ethylene, which could lead to new agricultural chemicals.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

The new filler effectively and safely improves tear trough deformity long-term.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Glycogen metabolism is important for energy and processes in human hair follicles, and hair follicles may produce glucose from lactate.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

miR-29 is a key factor that accelerates aging.

Certain molecules in hair change with age and could be used for cosmetic treatments.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

UV-induced autofluorescence is effective for identifying different types of alopecia.

Certain genes related to sulfur metabolism are more active during the growth phase of Cashmere goat wool, and melatonin might help this process.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Diet and nutrients, including lycopene from tomatoes and hydroquinone from wheat, can help control melasma, a skin condition.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

Adequate vitamin D might lower, and high hair chromium might increase DNA damage in obese women.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Exosomes from umbilical cord cells fix hearing loss and damaged ear hair cells in mice.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.